Case docket: Cephalon Inc. et al v. Watson Laboratories Inc.

Case details

Court:	ded
Docket #:	1:10-cv-00007
Case Name:	Cephalon Inc. et al v. Watson Laboratories Inc.
PACER case #:	43435
Date filed:	2010-01-05
Date terminated:	2013-03-30
Assigned to:	Judge Gregory M. Sleet
Case Cause:	35:271 Patent Infringement
Nature of Suit:	830 Patent
Jury Demand:	Defendant
Jurisdiction:	Federal Question

Parties

Represented Party	Attorney & Contact Info
Cephalon Inc. Plaintiff	Alan Richard Silverstein Potter Anderson & Corroon, LLP 1313 N. Market St., Hercules Plaza, 6th Flr. P.O. Box 951 Wilmington, DE 19899-0951 302 -252-3619 Email: asilverstein@potteranderson.com TERMINATED: 09/11/2013 LEAD ATTORNEY Jeffrey B. Bove Novak Druce Connolly Bove + Quigg LLP The Nemours Building 1007 North Orange Street P.O. Box 2207 Wilmington, DE 19899 (302)658-9141 Email: jeff.bove@novakdruce.com LEAD ATTORNEY ATTORNEY TO BE NOTICED Mary W. Bourke Womble Carlyle Sandridge Rice 222 Delaware Avenue Suite 1501 Wilmington, DE 19801 (302) 252-4320 Email: mbourke@wcsr.com TERMINATED: 09/11/2013 LEAD ATTORNEY Charles E. Lipsey Email: charles.lipsey@finnegan.com PRO HAC VICE ATTORNEY TO BE NOTICED John C. Englander Email: jenglander@goodwinprocter.com PRO HAC VICE ATTORNEY TO BE NOTICED Mark J. Feldstein Email: mark.feldstein@finnegan.com PRO HAC VICE ATTORNEY TO BE NOTICED
Cephalon France Plaintiff	Alan Richard Silverstein (See above for address) TERMINATED: 09/11/2013 LEAD ATTORNEY Jeffrey B. Bove (See above for address) LEAD ATTORNEY ATTORNEY TO BE NOTICED Mary W. Bourke (See above for address) TERMINATED: 09/11/2013 LEAD ATTORNEY Barbara R. Rudolph Email: barbara.rudolph@finnegan.com PRO HAC VICE ATTORNEY TO BE NOTICED Charles E. Lipsey (See above for address) PRO HAC VICE ATTORNEY TO BE NOTICED Mark J. Feldstein (See above for address) PRO HAC VICE ATTORNEY TO BE NOTICED
Watson Laboratories Inc. Defendant	John C. Phillips , Jr. Phillips, Goldman & Spence, P.A. 1200 North Broom Street Wilmington, DE 19806 (302) 655-4200 Email: jcp@pgslaw.com LEAD ATTORNEY ATTORNEY TO BE NOTICED Megan C. Haney Phillips, Goldman & Spence, P.A. 1200 North Broom Street Wilmington, DE 19806 302- 655-4200 Email: mch@pgslaw.com LEAD ATTORNEY ATTORNEY TO BE NOTICED Gina J. Oka Email: goka@winston.com TERMINATED: 02/29/2012 PRO HAC VICE James F. Hurst Email: james.hurst@kirkland.com PRO HAC VICE ATTORNEY TO BE NOTICED Kevin E. Warner Email: KWarner@winston.com PRO HAC VICE ATTORNEY TO BE NOTICED Michael K. Nutter Email: mnutter@winston.com PRO HAC VICE ATTORNEY TO BE NOTICED Brian E. Farnan Farnan LLP 919 North Market Street 12th Floor Wilmington, DE 19801 (302) 777-0300 Fax: (302) 777-0301 Email: bfarnan@farnanlaw.com ATTORNEY TO BE NOTICED
Watson Laboratories Inc. Counter Claimant	John C. Phillips , Jr. (See above for address) LEAD ATTORNEY ATTORNEY TO BE NOTICED Brian E. Farnan (See above for address) ATTORNEY TO BE NOTICED
Cephalon France Counter Defendant	Mary W. Bourke (See above for address) TERMINATED: 09/11/2013 LEAD ATTORNEY Jeffrey B. Bove (See above for address) ATTORNEY TO BE NOTICED
Cephalon Inc. Counter Defendant	Mary W. Bourke (See above for address) TERMINATED: 09/11/2013 LEAD ATTORNEY Jeffrey B. Bove (See above for address) ATTORNEY TO BE NOTICED

Documents

Date Filed	Document #	Attachment #	Short Description	Long Description	Upload date	SHA1 hash
2010-01-05	1	0		COMPLAINT filed against Watson Laboratories Inc., Watson Pharma Inc., Watson Pharmaceuticals Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 350, receipt number 0311-675819.) - filed by Cephalon Inc., Cephalon France. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(mxw, ) (Entered: 01/06/2010)
2010-01-05	2	0		Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction (mxw, ) (Entered: 01/06/2010)
2010-01-06	3	0		Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,132,570 B2; (mxw, ) (Entered: 01/06/2010)
2010-01-07	4	0		Disclosure Statement pursuant to Rule 7.1 filed by Cephalon France, Cephalon Inc.. (Bourke, Mary) (Entered: 01/07/2010)
2010-01-07	5	0		Disclosure Statement pursuant to Rule 7.1 filed by Cephalon France, Cephalon Inc.. (Bourke, Mary) (Entered: 01/07/2010)
2010-01-26	6	0		NOTICE of Lodging of Waiver of Service of Summons of Watson Laboratories, Inc. by Cephalon France, Cephalon Inc. (Bourke, Mary) (Entered: 01/26/2010)
2010-01-26	7	0		NOTICE of Lodging of Waiver of Service of Summons of Watson Pharma, Inc. by Cephalon France, Cephalon Inc. (Bourke, Mary) (Entered: 01/26/2010)
2010-01-26	8	0		NOTICE of Lodging of Waiver of Service of Summons of Watson Pharmaceuticals, Inc. by Cephalon France, Cephalon Inc. (Bourke, Mary) (Entered: 01/26/2010)
2010-01-26	9	0		STIPULATION of Dismissal STIPULATION AND ORDER DISMISSING WITHOUT PREJUDICE DEFENDANTS WATSON PHARMACEUTICALS, INC. AND WATSON PHARMA, INC. AND AMENDING CAPTION TO REFLECT SAME by Cephalon France, Cephalon Inc.. (Bourke, Mary) (Entered: 01/26/2010)
2010-02-01	10	0		ANSWER to 1 Complaint, with Jury Demand, COUNTERCLAIM against Cephalon France, Cephalon Inc. by Watson Laboratories Inc..(Farnan, Brian) (Entered: 02/01/2010)
2010-02-02	11	0		NOTICE of Appearance by John C. Phillips, Jr on behalf of Watson Laboratories Inc. (Phillips, John) (Entered: 02/02/2010)
2010-02-10	12	0		AMENDED DOCUMENT by Cephalon France, Cephalon Inc.. Amendment to 4 Disclosure Statement Amended Disclosure Statement of Cephalon Inc.. (Bourke, Mary) (Entered: 02/10/2010)
2010-02-22	13	0		Disclosure Statement pursuant to Rule 7.1 filed by Watson Laboratories Inc. identifying Corporate Parent Watson Pharmaceuticals, Inc. for Watson Laboratories Inc... (Phillips, John) (Entered: 02/22/2010)
2010-02-25	14	0		ANSWER to 10 Answer to Complaint, Counterclaim , and Affirmative Defenses by Cephalon France, Cephalon Inc..(Bourke, Mary) (Entered: 02/25/2010)
2010-03-01	15	0		MOTION for Pro Hac Vice Appearance of Attorney James Hurst, Michael Nutter and Kevin Warner - filed by Watson Laboratories Inc.. (Attachments: # 1 Hurst Pro Hac Certification, # 2 Nutter Pro Hac Certification, # 3 Warner Pro Hac Certification)(Phillips, John) (Entered: 03/01/2010)
2010-03-30	16	0		STIPULATION ORDER TO CONSOLIDATE RELATED CASES FOR PRETRIAL PURPOSES by Cephalon France, Cephalon Inc.. (Bourke, Mary) (Entered: 03/30/2010)
2010-04-07	17	0		NOTICE OF SERVICE of Watson Laboratories, Inc.'s First Set of Rule 34 Requests to Plaintiffs by Watson Laboratories Inc..(Phillips, John) (Entered: 04/07/2010)
2010-04-16	18	0		NOTICE OF SERVICE of Defendants' First Set of Common Interrogatories to Plaintiffs by Mylan Pharmaceuticals Inc..(Higgins, James) (Entered: 04/16/2010)
2010-04-21	19	0		NOTICE OF SERVICE of Watson Laboratories, Inc.'s Second Set of Rule 34 Requests to Plaintiffs by Watson Laboratories Inc..(Farnan, Brian) (Entered: 04/21/2010)
2010-04-26	20	0		SO ORDERED, re (19 in 1:09-cv-00940-GMS, 7 in 1:10-cv-00210-GMS, 16 in 1:10-cv-00007-GMS, 20 in 1:09-cv-00954-GMS, 13 in 1:10-cv-00055-GMS, 15 in 1:09-cv-00918-GMS) Stipulation filed by Cephalon France, Cephalon Inc. Cases consolidated for all pretrial purposes. All pretrial filings shall be made in Civil Action No. 09-918 and shall be captioned solely with the caption from 09-918. Signed by Chief Judge Gregory M. Sleet on 4/26/10. Associated Cases: 1:09-cv-00918-GMS et al.(mmm) (Entered: 04/26/2010)
2010-04-30	21	0		NOTICE OF SERVICE of Watson Laboratories, Inc.'s Initial Disclosures Pursuant to Rule 26(a)(1) by Watson Laboratories Inc..(Farnan, Brian) (Entered: 04/30/2010)
2010-09-14	22	0		MOTION for Pro Hac Vice Appearance of Attorney Gina J. Oka - filed by Watson Laboratories Inc.. (Attachments: # 1 Pro Hac Certification)(Haney, Megan) (Entered: 09/14/2010)
2010-09-24	23	0		MOTION for Pro Hac Vice Appearance of Attorney Charles E. Lipsey, Barbara R. Rudolph, and Mark J. Feldstein - filed by Cephalon France, Cephalon Inc.. (Bourke, Mary) (Entered: 09/24/2010)
2010-12-08	24	0		TRANSFER ORDER from Judicial Panel on Multidistrict Litigation including this action in MDL 2200 filed in the District of Delaware. (dzs, ) (Entered: 12/10/2010)
2011-05-18	25	0		CLAIM Construction Chart by Cephalon France, Cephalon Inc., Watson Laboratories Inc., Apotex Corp., Apotex, Inc., Cephalon, Inc., Sandoz Inc., Lupin Limited, Armodafinil Patent Litigation, Mylan Pharmaceuticals Inc.. (Bourke, Mary) (Entered: 05/18/2011)
2011-06-01	26	0		CLAIM CONSTRUCTION OPENING BRIEF FOR U.S. PATENT NO. 7,132,570 filed by Cephalon France, Cephalon Inc.. (Bourke, Mary) (Entered: 06/01/2011)
2011-06-01	27	0		DECLARATION re (75 in 1:10-md-02200-GMS) Claim Construction Opening Brief, (80 in 1:10-cv-01078-GMS) Claim Construction Opening Brief, (28 in 1:09-cv-00954-GMS) Claim Construction Opening Brief, (21 in 1:10-cv-00210-GMS) Claim Construction Opening Brief, (26 in 1:10-cv-00007-GMS) Claim Construction Opening Brief, (26 in 1:10-cv-00055-GMS) Claim Construction Opening Brief DECLARATION OF PROFESSOR ALLAN S. MYERSON, PH.D. by Cephalon France, Cephalon Inc., Cephalon, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H)(Bourke, Mary) (Entered: 06/01/2011)
2011-06-01	28	0		Joint CLAIM CONSTRUCTION OPENING BRIEF filed by Watson Laboratories Inc.. (Keller, Karen) (Entered: 06/01/2011)
2011-06-07	29	0		Letter to The Honorable Gregory M. Sleet from Mary W. Bourke regarding Amended Proposed Scheduling Order. (Attachments: # 1 Amended Proposed Scheduling Order)(Bourke, Mary) (Entered: 06/07/2011)
2011-06-15	30	0		Joint APPENDIX OF INTRINSIC AND EXTRINSIC EVIDENCE FOR U.S. PATENT NO. 7,132,570 by Cephalon France, Cephalon Inc., Cephalon, Inc.. (Attachments: # 1 JX 1, # 2 JX 2, # 3 JX 3, # 4 JX 4, # 5 JX 5, # 6 JX 6, # 7 JX 7, # 8 JX 8, # 9 JX 9, # 10 JX 10, # 11 JX 11, # 12 JX 12, # 13 JX 13, # 14 JX 14, # 15 JX 15, # 16 JX 16)(Bourke, Mary) (Entered: 06/15/2011)
2011-06-15	31	0		NOTICE of filing the following document(s) in paper format: JOINT APPENDIX (JX) NUMBER 17 TO THE JOINT APPENDIX OF INTRINSIC AND EXTRINSIC EVIDENCE FOR U.S. PATENT NO. 7,132,570. Original document(s) to be filed with the Clerk's Office. Notice filed by Mary W. Bourke on behalf of Cephalon France, Cephalon Inc., Cephalon, Inc. (Bourke, Mary) (Entered: 06/15/2011)
2011-06-15	32	0		CLAIM CONSTRUCTION ANSWERING BRIEF re 26 Claim Construction Opening Brief Defendants' Responsive Claim Construction Brief filed by Watson Laboratories Inc.. (Keller, Karen) (Entered: 06/15/2011)
2011-06-15	33	0		CLAIM CONSTRUCTION ANSWERING BRIEF re 28 Claim Construction Opening Brief FOR U.S. PATENT NO. 7,132,570 filed by Cephalon France, Cephalon Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C)(Bourke, Mary) (Entered: 06/15/2011)
2011-06-15	34	0		DECLARATION re (29 in 1:10-cv-00210-GMS) Claim Construction Answering Brief, (37 in 1:09-cv-00954-GMS) Claim Construction Answering Brief, (91 in 1:10-md-02200-GMS) Claim Construction Answering Brief, (89 in 1:10-cv-01078-GMS) Claim Construction Answering Brief, (33 in 1:10-cv-00055-GMS) Claim Construction Answering Brief, (33 in 1:10-cv-00007-GMS) Claim Construction Answering Brief DECLARATION OF SIMON BATES, PH.D. by Cephalon France, Cephalon Inc., Cephalon, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Bourke, Mary) (Entered: 06/15/2011)
2011-06-16	35	0		Joint CLAIM CONSTRUCTION OPENING BRIEF - CORRECTED [to add Joint Appendix ("JA") cites not previously available] - filed by Watson Laboratories Inc.. (Keller, Karen) (Entered: 06/16/2011)
2011-06-16	36	0		JOINT APPENDIX of Intrinsic and Extrinsic Evidence for U.S. Patent No. 7,132,570 (Vol. 1 of 4) (see 31 Notice of Filing Paper Documents). (nms) (Entered: 06/16/2011)
2011-06-16	37	0		JOINT APPENDIX of Intrinsic and Extrinsic Evidence for U.S. Patent No. 7,132,570 (Vol. 2 of 4) (see 31 Notice of Filing Paper Documents). (nms) (Entered: 06/16/2011)
2011-06-16	38	0		JOINT APPENDIX of Intrinsic and Extrinsic Evidence for U.S. Patent No. 7,132,570 (Vol. 3 of 4) (see 31 Notice of Filing Paper Documents). (nms) (Entered: 06/16/2011)
2011-06-16	39	0		JOINT APPENDIX of Intrinsic and Extrinsic Evidence for U.S. Patent No. 7,132,570 (Vol. 4 of 4) (see 31 Notice of Filing Paper Documents). (nms) (Entered: 06/16/2011)
2011-06-17	40	0		CLAIM CONSTRUCTION OPENING BRIEF for Patent No. 7,132,570 - CORRECTED [ to add Joint Appendix "JA" cites not previously available] filed by Cephalon France, Cephalon Inc.. (Bourke, Mary) (Entered: 06/17/2011)
2011-06-17	41	0		DECLARATION re (40 in 1:10-cv-00055-GMS) Claim Construction Opening Brief, (40 in 1:10-cv-00007-GMS) Claim Construction Opening Brief, (99 in 1:10-md-02200-GMS) Claim Construction Opening Brief, (36 in 1:10-cv-00210-GMS) Claim Construction Opening Brief, (44 in 1:09-cv-00954-GMS) Claim Construction Opening Brief, (96 in 1:10-cv-01078-GMS) Claim Construction Opening Brief in Support of Brief Re: Patent No. 7,132,570 - CORRECTED [ to add Joint Appendix "JA" cites not previously available] by Cephalon France, Cephalon Inc., Cephalon, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H)(Bourke, Mary) (Entered: 06/17/2011)
2011-06-21	42	0		NOTICE OF SERVICE of Cephalon's Notice of Deposition of Watson Laboratories, Inc. Pursuant to Rule 30(b)(6) by Cephalon France, Cephalon Inc..(Bourke, Mary) (Entered: 06/21/2011)
2011-06-22	43	0		NOTICE OF SERVICE of Cephalon's Second Notice of Deposition of Watson Laboratories Inc. Pursuant to Rule 30(b)(6) by Cephalon France, Cephalon Inc..(Bourke, Mary) (Entered: 06/22/2011)
2011-06-22	44	0		NOTICE OF SERVICE of 1) CEPHALONS NOTICE OF DEPOSITION OF MICHAEL BROWN; 2) CEPHALONS NOTICE OF DEPOSITION OF HIREN PATEL; and 3) CEPHALONS NOTICE OF DEPOSITION OF BHAVESH PATEL by Cephalon France, Cephalon Inc..(Bourke, Mary) (Entered: 06/22/2011)
2011-06-29	45	0		Joint NOTICE of Deposition Of Plaintiffs Cephalon Inc. And Cephalon France Pursuant to Fed.R.Civ.P.30(b)(6) [FIRST NOTICE] by Watson Laboratories Inc., Apotex Corp., Apotex Inc., Lupin Limited, Mylan Pharmaceuticals Inc., Sandoz Inc., Apotex, Inc. (Keller, Karen) (Entered: 06/29/2011)
2011-07-05	46	0		NOTICE OF SERVICE of Plaintiffs' Second Supplemental Responses to Defendants' Common Interrogatories to Plaintiffs Nos. 5 & 8 by Cephalon France, Cephalon Inc..(Bourke, Mary) (Entered: 07/05/2011)
2011-07-07	47	0		NOTICE of Subpoenas by Cephalon France, Cephalon Inc. Subpoenas to 1. ScinoPharm Chemicals, LLC 2. ScinoPharm Taiwan, Ltd. 3. ScinoPharm International Ltd. (Bourke, Mary) (Entered: 07/07/2011)
2011-07-07	48	0		MOTION for Pro Hac Vice Appearance of Attorney 1. Sanya Sukduang 2. Jennifer A. Johnson 3. Mayssam H. Ali - filed by Cephalon France, Cephalon Inc., Cephalon, Inc.. (Bourke, Mary) (Entered: 07/07/2011)
2011-07-07	49	0		NOTICE OF SERVICE of Plaintiffs' Third Requests to Watson Laboratories, Inc. for the Production of Documents and Things (Nos. 87-93) by Cephalon France, Cephalon Inc..(Bourke, Mary) (Entered: 07/07/2011)
2011-07-08	50	0		SUBPOENA Returned Executed as to ScinoPharm Chemicals, LLC on 7/7/2011 (Bourke, Mary) (Entered: 07/08/2011)
2011-07-08	51	0		NOTICE OF SERVICE of Watson Laboratories, Inc.'s Objections and Responses to Cephalon's Second Notice of Deposition Pursuant to Fed. R. Civ. P. 30(b)(6) and Watson Laboratories, Inc.'s Objections and Responses to Cephalon's Notice of Deposition Pursuant to Fed. R. Civ. P. 30(b)(6) re (108 in 1:10-md-02200-GMS) Notice of Service, (114 in 1:10-md-02200-GMS) Notice of Service by Watson Laboratories Inc.. Related document: (108 in 1:10-md-02200-GMS) Notice of Service filed by Cephalon France, Cephalon Inc., (114 in 1:10-md-02200-GMS) Notice of Service filed by Cephalon France, Cephalon Inc..(Phillips, John) (Entered: 07/08/2011)
2011-07-11	52	0		MOTION for Pro Hac Vice Appearance of Attorney William B. Raich - filed by Cephalon France, Cephalon Inc., Cephalon, Inc.. (Bourke, Mary) (Entered: 07/11/2011)
2011-07-12	53	0		SUBPOENA Returned Executed as to ScinoPharm Taiwan, Ltd. on 7/8/11 (Bourke, Mary) (Entered: 07/12/2011)
2011-07-12	54	0		SUBPOENA Returned Executed as to ScinoPharm International, Ltd. on 7/7/11 (Bourke, Mary) (Entered: 07/12/2011)
2011-07-15	55	0		NOTICE to Take Deposition of Robert T. Hrubiec on August 11, 2011 by Watson Laboratories Inc., Sandoz Inc., Lupin Limited, Mylan Pharmaceuticals Inc..(Phillips, John) (Entered: 07/15/2011)
2011-07-15	56	0		NOTICE to Take Deposition of Armando Cortes on August 10, 2011 by Watson Laboratories Inc., Sandoz Inc., Lupin Limited, Mylan Pharmaceuticals Inc..(Phillips, John) (Entered: 07/15/2011)
2011-07-15	57	0		NOTICE to Take Deposition of Colleen Murray on August 9, 2011 by Watson Laboratories Inc., Sandoz Inc., Lupin Limited, Mylan Pharmaceuticals Inc..(Phillips, John) (Entered: 07/15/2011)
2011-07-15	58	0		NOTICE to Take Deposition of Paul Kirsch on August 8, 2011 by Watson Laboratories Inc., Sandoz Inc., Lupin Limited, Mylan Pharmaceuticals Inc..(Phillips, John) (Entered: 07/15/2011)
2011-07-15	59	0		NOTICE OF SERVICE of Watson Laboratories, Inc.'s Supplemental Responses to Plaintiffs' First and Second Sets of Interrogatories (Nos. 5, 6, 8, 9, 13, 15 and 17) by Watson Laboratories Inc..(Phillips, John) (Entered: 07/15/2011)
2011-07-15	60	0		NOTICE to Take Deposition of Matthew L. Peterson on August 11-12, 2011 by Lupin Limited, Mylan Pharmaceuticals Inc., Sandoz Inc., Watson Laboratories Inc..(Keller, Karen) (Entered: 07/15/2011)
2011-07-15	61	0		NOTICE to Take Deposition of Erwin Blomsma on August 15-16, 2011 by Lupin Limited, Mylan Pharmaceuticals Inc., Sandoz Inc., Watson Laboratories Inc..(Keller, Karen) (Entered: 07/15/2011)
2011-07-15	62	0		NOTICE to Take Deposition of John P. Mallamo on August 17-18, 2011 by Lupin Limited, Mylan Pharmaceuticals Inc., Sandoz Inc., Watson Laboratories Inc..(Keller, Karen) (Entered: 07/15/2011)
2011-07-19	63	0		NOTICE of Withdrawal of Attorney Thomas L. Irving for Plaintiffs by Cephalon France, Cephalon Inc., Cephalon, Inc. (Bourke, Mary) (Entered: 07/19/2011)
2011-07-20	64	0		NOTICE OF SERVICE of Plaintiffs' Third Set of Interrogatories (Nos. 18-20) to Watson Laboratories Inc. by Cephalon France, Cephalon Inc..(Bourke, Mary) (Entered: 07/20/2011)
2011-07-20	65	0		NOTICE OF SERVICE of (1) Defendants' Third Set Of Common Interrogatories To Plaintiffs (2) Defendants' First Set Of Common Requests For Admissions To Plaintiffs by Mylan Pharmaceuticals Inc..(Keller, Karen) (Entered: 07/20/2011)
2011-07-21	66	0		NOTICE OF SERVICE of Plaintiffs' Third Set of Interrogatories (Nos. 18-20) to Watson Laboratories, Inc. by Cephalon France, Cephalon Inc..(Bourke, Mary) (Entered: 07/21/2011)
2011-07-26	67	0		NOTICE OF SERVICE of Plaintiff's First Objections to Defendants' First Notice of Deposition of Plaintiffs Cephalon Inc. and Cephalon France Pursuant to Fed. R. Civ. P. 30(b)(6) by Cephalon France, Cephalon Inc., Cephalon, Inc..(Bourke, Mary) (Entered: 07/26/2011)
2011-08-01	68	0		NOTICE OF SERVICE of Cephalon's Third Notice of Deposition of Watson Laboratories Inc. Pursuant to Rule 30(b)(6) by Cephalon France, Cephalon Inc..(Bourke, Mary) (Entered: 08/01/2011)
2011-08-05	69	0		NOTICE OF SERVICE of Watson Laboratories, Inc.'s Second Set of Supplemental Responses to Plaintiffs' First and Second Set of Interrogatories (Nos. 3, 4, 10, 11 & 14) by Watson Laboratories Inc..(Phillips, John) (Entered: 08/05/2011)
2011-08-09	70	0		NOTICE OF SERVICE of Watson Laboratories, Inc.'s Objections and Responses to Plaintiffs' Third Set of Requests to Watson Laboratories, Inc. for the Production of Documents and Things (Nos. 81-93) by Watson Laboratories Inc..(Phillips, John) (Entered: 08/09/2011)
2011-08-17	71	0		NOTICE OF SERVICE of Plaintiff's First Objections to Defendants' Second Notice of Deposition of Plaintiffs Cephalon Inc. and Cephalon France Pursuant to Fed. R. Civ. P. 30(b)(6) by Cephalon France, Cephalon Inc., Cephalon, Inc..(Bourke, Mary) (Entered: 08/17/2011)
2011-08-18	72	0		MOTION for Pro Hac Vice Appearance of Attorney Jovial Wong - filed by Watson Laboratories Inc.. (Attachments: # 1 Pro Hac Certification)(Phillips, John) (Entered: 08/18/2011)
2011-08-19	73	0		NOTICE OF SERVICE of (1) Watson Laboratories, Inc.'s Objections and Responses to Plaintiffs' Third Set of Interrogatories (Nos. 18-20); and (2) Watson Laboratories, Inc.'s Third Set of Supplemental Responses to Plaintiffs' First Set of Interrogatories (No. 11) by Watson Laboratories Inc..(Phillips, John) (Entered: 08/19/2011)
2011-08-19	74	0		NOTICE OF SERVICE of PLAINTIFFS RESPONSE TO DEFENDANTS FIRST SET OF COMMON REQUESTS FOR ADMISSION TO PLAINTIFFS and PLAINTIFFS RESPONSE TO DEFENDANTS THIRD SET OF COMMON INTERROGATORIES TO PLAINTIFFS by Cephalon France, Cephalon Inc., Cephalon, Inc..(Bourke, Mary) (Entered: 08/19/2011)
2011-08-26	75	0		Joint Letter to The Honorable Gregory M. Sleet from Mary W. Bourke and on behalf of all parties regarding Agenda for 9/1/11 Discovery Teleconference. (Bourke, Mary) (Entered: 08/26/2011)
2011-09-14	76	0		Joint STIPULATION TO EXTEND TIME to EXTEND discovery and subsequent deadlines to September 23, 2011-March 16, 2012 - filed by Cephalon France, Cephalon Inc., Watson Laboratories Inc., Mylan Pharmaceuticals Inc., Sandoz Inc., Apotex Corp., Apotex, Inc., Cephalon, Inc., Lupin Limited, Lupin Pharmaceuticals Inc., Apotex Inc.. (Bourke, Mary) (Entered: 09/14/2011)
2011-09-23	77	0		NOTICE OF SERVICE of Cephalon, Inc. and Cephalon France's Supplemental Initial Disclosure Statement Pursuant to Fed. R. Civ. P. 26(a)(1) by Cephalon France, Cephalon Inc., Cephalon, Inc..(Bourke, Mary) (Entered: 09/23/2011)
2011-09-26	78	0		SO ORDERED, re 76 Joint STIPULATION TO EXTEND TIME to EXTEND discovery and subsequent deadlines to September 23, 2011-March 16, 2012 filed by Lupin Limited, Apotex Inc., Apotex Corp., Cephalon France, Cephalon Inc., Mylan Pharmaceuticals Inc., Cephalon, Inc., Apotex, Inc., Lupin Pharmaceuticals Inc., Sandoz Inc., Watson Laboratories Inc., ORDER, Resetting Deadlines: ( Fact Discovery due by 9/23/2011., Expert Reports: Opening due by 10/20/2011, Answering due by 11/18/2011, Rebuttal due by 12/12/2011, Completion of Expert Discovery due by 2/3/2012., Proposed Pretrial Order due by 3/16/2012.). Signed by Chief Judge Gregory M. Sleet on 9/16/2011. (asw) (Entered: 09/26/2011)
2011-10-20	79	0		Joint STIPULATION TO EXTEND TIME for the parties to serve opening expert reports to October 24, 2011 - filed by Cephalon France, Cephalon Inc., Lupin Limited, Mylan Pharmaceuticals Inc., Sandoz Inc., Watson Laboratories Inc., Apotex Corp., Apotex Inc.. (Shaw, John) (Entered: 10/20/2011)
2011-10-24	80	0		NOTICE OF SERVICE of EXPERT REPORT OF ALLAN S. MYERSON, Ph.D., and EXPERT REPORT OF K. TRAVIS HOLMAN, Ph.D. by Cephalon France, Cephalon Inc..(Bourke, Mary) (Entered: 10/24/2011)
2011-10-25	81	0		NOTICE OF SERVICE of Opening Expert Report of Dr. Mark Hollingsworth (on behalf of Defendants Mylan Pharmaceuticals Inc., Watson Laboratories, Inc., Sandoz Inc. and Lupin Limited) by Mylan Pharmaceuticals Inc..(Keller, Karen) (Entered: 10/25/2011)
2011-11-04	82	0		AMENDED DOCUMENT by Cephalon France. Amended Disclosure Statement of Cephalon France. (Bourke, Mary) (Entered: 11/04/2011)
2011-11-04	83	0		AMENDED DOCUMENT by Cephalon Inc., Cephalon, Inc.. Amended Disclosure Statement of Cephalon, Inc.. (Bourke, Mary) (Entered: 11/04/2011)
2011-11-16	84	0		Joint MOTION for Extension of Time to File Responsive and Rebuttal Expert Reports - filed by Cephalon France, Cephalon Inc., Watson Laboratories Inc., Mylan Pharmaceuticals Inc., Sandoz Inc., Apotex Corp., Apotex, Inc., Cephalon, Inc., Lupin Limited, Lupin Pharmaceuticals Inc., Apotex Inc.. (Bourke, Mary) (Entered: 11/16/2011)
2011-11-23	85	0		NOTICE OF SERVICE of (1) EXPERT REPORT OF JON G. SELBO, Ph.D.; (2) EXPERT REPORT OF DANIEL T. SMITH, Ph.D.; (3) EXPERT REPORT OF LEONARD J. CHYALL, Ph.D.; (4) EXPERT REPORT OF FREDERICK A. STEARNS; (5) RESPONSIVE EXPERT WITNESS REPORT OF JOEL BERNSTEIN, Ph.D.; (6) RESPONSIVE EXPERT REPORT OF JONATHAN R.L. SCHWARTZ, M.D.; and (7) RESPONSIVE EXPERT REPORT OF ALLAN S. MYERSON, Ph.D. by Cephalon France, Cephalon Inc., Cephalon, Inc..(Bourke, Mary) (Entered: 11/23/2011)
2011-12-08	86	0		MOTION for Pro Hac Vice Appearance of Attorney Daryl L. Wiesen & John C. Englander - filed by Cephalon France, Cephalon Inc., Cephalon, Inc.. (Bourke, Mary) (Entered: 12/08/2011)
2011-12-15	87	0		Joint STIPULATION TO EXTEND TIME to Serve Rebuttal Expert Reports to December 20, 2011 - filed by Cephalon France, Cephalon Inc., Watson Laboratories Inc., Mylan Pharmaceuticals Inc., Sandoz Inc., Apotex Corp., Apotex, Inc., Lupin Limited. (Keller, Karen) (Entered: 12/15/2011)
2011-12-30	88	0		NOTICE OF SERVICE of 1. CEPHALONS NOTICE OF DEPOSITION OF JERRY L. ATWOOD, Ph.D..; 2. CEPHALONS NOTICE OF DEPOSITION OF MICHAEL CIMA, Ph.D.; 3. CEPHALONS NOTICE OF DEPOSITION OF DR. MARK HOLLINGSWORTH, Ph.D.; 4. CEPHALONS NOTICE OF DEPOSITION OF ALBERT C. LEE, Ph.D.; 5. CEPHALONS NOTICE OF DEPOSITION OF STEPHEN B. ROBIE, Ph.D.; 6. CEPHALONS NOTICE OF DEPOSITION OF MICHAEL J. ZAWOROTKO by Cephalon France, Cephalon Inc., Cephalon, Inc..(Bourke, Mary) (Entered: 12/30/2011)
2012-01-04	89	0		MOTION To Narrow Order Regarding Secondary Considerations of Non-Obviousness - filed by Cephalon France, Cephalon Inc., Cephalon, Inc.. (Attachments: # 1 Text of Proposed Order, # 2 Exhibit A, # 3 Exhibit B, # 4 Exhibit C, # 5 Exhibit D)(Bourke, Mary) (Entered: 01/04/2012)
2012-01-10	90	0		NOTICE to Take Deposition of Joel Bernstein, Ph.D. on January 12, 2012 by Watson Laboratories Inc., Mylan Pharmaceuticals Inc., Sandoz Inc., Apotex Corp., Apotex, Inc., Lupin Limited.(Keller, Karen) (Entered: 01/10/2012)
2012-01-24	91	0		SEALED ANSWERING BRIEF in Opposition re 89 MOTION To Narrow Order Regarding Secondary Considerations of Non-Obviousness [Filed in 1:10-md-2200-GMS on 1/23/2012] filed by Watson Laboratories Inc..Reply Brief due date per Local Rules is 2/3/2012. (Attachments: # 1 Exhibit 1 through 18)(Haney, Megan) (Entered: 01/24/2012)
2012-01-31	92	0		REDACTED VERSION of 91 Answering Brief in Opposition, by Watson Laboratories Inc.. (Haney, Megan) (Entered: 01/31/2012)
2012-01-31	93	0		Joint STIPULATION TO EXTEND TIME Plaintiff's Reply Brief in Response to Defendants' Answering Brief in Opposition to Plaintiffs' Motion to Narrow Order Regarding Secondary Considerations of Non-Obviousness to February 9, 2012 - filed by Cephalon France, Cephalon Inc., Watson Laboratories Inc., Sandoz Inc., Mylan Pharmaceuticals Inc., Lupin Limited, Apotex Corp., Apotex Inc.. (Bourke, Mary) (Entered: 01/31/2012)
2012-02-09	94	0		SEALED REPLY BRIEF re 89 MOTION To Narrow Order Regarding Secondary Considerations of Non-Obviousness filed by Cephalon France, Cephalon Inc.. (Attachments: # 1 Exhibit A-K)(Bourke, Mary) (Entered: 02/09/2012)
2012-02-29	95	0		NOTICE requesting Clerk to remove Gina J. Oka as co-counsel. Reason for request: No longer with Winston & Strawn LLP. (Haney, Megan) (Entered: 02/29/2012)
2012-03-13	96	0		Letter to The Honorable Gregory M. Sleet from Mary W. Bourke regarding 30- Month Stay. (Bourke, Mary) (Entered: 03/13/2012)
2012-03-30	97	0		NOTICE OF SERVICE of 1. Supplemental Expert Report of Daniel T. Smith, Ph.D. and 2. Supplemental Expert Report of Leonard J. Chyall, Ph.D. by Cephalon France, Cephalon Inc., Cephalon, Inc..(Bourke, Mary) (Entered: 03/30/2012)
2012-03-31	98	0		Proposed Pretrial Order (PROPOSED JOINT PRETRIAL ORDER) (Confidential Exhibits M and N Filed Separately Under Seal) by Cephalon France, Cephalon Inc., Watson Laboratories Inc., Sandoz Inc., Apotex Corp., Apotex Inc., Lupin Limited, Mylan Pharmaceuticals Inc., Apotex, Inc., Cephalon, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit G-1, # 9 Exhibit G-2, # 10 Exhibit G-3, # 11 Exhibit H, # 12 Exhibit I, # 13 Exhibit I-1, # 14 Exhibit I-2, # 15 Exhibit J, # 16 Exhibit K, # 17 Exhibit K-1, # 18 Exhibit K-2, # 19 Exhibit L, # 20 Exhibit M, # 21 Exhibit N, # 22 Exhibit O, # 23 Exhibit P)(Bourke, Mary) (Entered: 03/31/2012)
2012-03-31	99	0		SEALED EXHIBIT re (28 in 1:11-cv-00782-GMS) Proposed Pretrial Order,, Exhibits M and N by Cephalon France, Cephalon Inc., Watson Laboratories Inc., Sandoz Inc., Apotex Corp., Apotex Inc., Lupin Limited, Mylan Pharmaceuticals Inc., Apotex, Inc., Cephalon, Inc.. (Attachments: # 1 Exhibit M and N)(Bourke, Mary) (Entered: 03/31/2012)
2012-04-03	100	0		SEALED MOTION for Temporary Restraining Order and a Preliminary Injunction - filed by Cephalon France, Cephalon Inc., Cephalon, Inc.. (Attachments: # 1 Text of Proposed Order)(Bourke, Mary) (Entered: 04/03/2012)
2012-04-03	101	0		SEALED OPENING BRIEF in Support re 100 SEALED MOTION for Temporary Restraining Order and a Preliminary Injunction filed by Cephalon France, Cephalon Inc..Answering Brief/Response due date per Local Rules is 4/20/2012. (Bourke, Mary) (Entered: 04/03/2012)
2012-04-03	102	0		SEALED DECLARATION re (94 in 1:10-cv-00055-GMS, 102 in 1:09-cv-00954-GMS, 262 in 1:10-md-02200-GMS, 115 in 1:10-cv-00695-GMS, 95 in 1:10-cv-00210-GMS, 100 in 1:10-cv-00007-GMS, 159 in 1:10-cv-01078-GMS, 30 in 1:11-cv-00782-GMS) SEALED MOTION for Temporary Restraining Order and a Preliminary Injunction of Mary W. Bourke by Cephalon France, Cephalon Inc., Cephalon, Inc.. (Attachments: # 1 Exhibit 1-18)(Bourke, Mary) (Entered: 04/03/2012)
2012-04-03	103	0		SEALED DECLARATION re (94 in 1:10-cv-00055-GMS, 102 in 1:09-cv-00954-GMS, 262 in 1:10-md-02200-GMS, 115 in 1:10-cv-00695-GMS, 95 in 1:10-cv-00210-GMS, 100 in 1:10-cv-00007-GMS, 159 in 1:10-cv-01078-GMS, 30 in 1:11-cv-00782-GMS) SEALED MOTION for Temporary Restraining Order and a Preliminary Injunction of Jerry A. Hausman by Cephalon France, Cephalon Inc., Cephalon, Inc.. (Attachments: # 1 Exhibit 1)(Bourke, Mary) (Entered: 04/03/2012)
2012-04-03	104	0		SEALED DECLARATION re (102 in 1:09-cv-00954-GMS) SEALED MOTION for Temporary Restraining Order and a Preliminary Injunction of Michael Derkacz by Cephalon France, Cephalon Inc., Cephalon, Inc.. (Bourke, Mary) (Entered: 04/03/2012)
2012-04-06	105	0		REDACTED VERSION of (157 in 1:10-cv-01078-GMS, 99 in 1:10-cv-00007-GMS, 260 in 1:10-md-02200-GMS, 101 in 1:09-cv-00954-GMS, 113 in 1:10-cv-00695-GMS, 93 in 1:10-cv-00055-GMS, 29 in 1:11-cv-00782-GMS, 94 in 1:10-cv-00210-GMS) Exhibit to a Document, by Cephalon France, Cephalon Inc., Watson Laboratories Inc., Sandoz Inc., Apotex Corp., Apotex Inc., Mylan Pharmaceuticals Inc., Cephalon, Inc., Lupin Limited. (Bourke, Mary) (Entered: 04/06/2012)
2012-04-10	106	0		REDACTED VERSION of (94 in 1:10-cv-00055-GMS, 102 in 1:09-cv-00954-GMS, 115 in 1:10-cv-00695-GMS, 95 in 1:10-cv-00210-GMS, 100 in 1:10-cv-00007-GMS, 159 in 1:10-cv-01078-GMS, 30 in 1:11-cv-00782-GMS) SEALED MOTION for Temporary Restraining Order and a Preliminary Injunction by Cephalon France, Cephalon Inc., Cephalon, Inc.. (Attachments: # 1 Text of Proposed Order)(Bourke, Mary) (Entered: 04/10/2012)
2012-04-10	107	0		REDACTED VERSION of (96 in 1:10-cv-00210-GMS) Opening Brief in Support, (160 in 1:10-cv-01078-GMS) Opening Brief in Support, (101 in 1:10-cv-00007-GMS) Opening Brief in Support, (263 in 1:10-md-02200-GMS) Opening Brief in Support, (116 in 1:10-cv-00695-GMS) Opening Brief in Support, (95 in 1:10-cv-00055-GMS) Opening Brief in Support, (31 in 1:11-cv-00782-GMS) Opening Brief in Support, (103 in 1:09-cv-00954-GMS) Opening Brief in Support by Cephalon France, Cephalon Inc., Cephalon, Inc.. (Bourke, Mary) (Entered: 04/10/2012)
2012-04-10	108	0		REDACTED VERSION of (264 in 1:10-md-02200-GMS, 97 in 1:10-cv-00210-GMS, 32 in 1:11-cv-00782-GMS, 117 in 1:10-cv-00695-GMS, 102 in 1:10-cv-00007-GMS, 104 in 1:09-cv-00954-GMS, 96 in 1:10-cv-00055-GMS, 161 in 1:10-cv-01078-GMS) Declaration, of Mary W. Bourke by Cephalon France, Cephalon Inc., Cephalon, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12 - 17, # 13 Exhibit 18)(Bourke, Mary) (Entered: 04/10/2012)
2012-04-10	109	0		REDACTED VERSION of (118 in 1:10-cv-00695-GMS, 33 in 1:11-cv-00782-GMS, 103 in 1:10-cv-00007-GMS, 98 in 1:10-cv-00210-GMS, 97 in 1:10-cv-00055-GMS, 265 in 1:10-md-02200-GMS, 162 in 1:10-cv-01078-GMS, 105 in 1:09-cv-00954-GMS) Declaration, of Jerry A. Hausman by Cephalon France, Cephalon Inc., Cephalon, Inc.. (Attachments: # 1 Exhibit 1)(Bourke, Mary) (Entered: 04/10/2012)
2012-04-10	110	0		REDACTED VERSION of (98 in 1:10-cv-00055-GMS, 163 in 1:10-cv-01078-GMS, 266 in 1:10-md-02200-GMS, 104 in 1:10-cv-00007-GMS, 106 in 1:09-cv-00954-GMS, 99 in 1:10-cv-00210-GMS, 34 in 1:11-cv-00782-GMS, 119 in 1:10-cv-00695-GMS) Declaration of Michael Derkacz by Cephalon France, Cephalon Inc., Cephalon, Inc.. (Bourke, Mary) (Entered: 04/10/2012)
2012-04-20	111	0		SEALED ANSWERING BRIEF in Opposition re 100 SEALED MOTION for Temporary Restraining Order and a Preliminary Injunction filed by Watson Laboratories Inc..Reply Brief due date per Local Rules is 4/30/2012. (Phillips, John) (Entered: 04/20/2012)
2012-04-24	112	0		SEALED REPLY BRIEF re 100 SEALED MOTION for Temporary Restraining Order and a Preliminary Injunction filed by Cephalon France, Cephalon Inc.. (Bourke, Mary) (Entered: 04/24/2012)
2012-04-24	113	0		SEALED DECLARATION re (112 in 1:10-cv-00007-GMS) Reply Brief, (171 in 1:10-cv-01078-GMS) Reply Brief, (106 in 1:10-cv-00055-GMS) Reply Brief, (107 in 1:10-cv-00210-GMS) Reply Brief, (42 in 1:11-cv-00782-GMS) Reply Brief, (279 in 1:10-md-02200-GMS) Reply Brief, (117 in 1:09-cv-00954-GMS) Reply Brief, (127 in 1:10-cv-00695-GMS) Reply Brief Declaration of Mary W. Bourke by Cephalon France, Cephalon Inc., Cephalon, Inc.. (Attachments: # 1 Exhibit 1-15 Sealed)(Bourke, Mary) (Entered: 04/24/2012)
2012-04-24	114	0		REQUEST for Oral Argument by Cephalon France, Cephalon Inc., Cephalon, Inc. re (94 in 1:10-cv-00055-GMS, 102 in 1:09-cv-00954-GMS, 262 in 1:10-md-02200-GMS, 115 in 1:10-cv-00695-GMS, 95 in 1:10-cv-00210-GMS, 100 in 1:10-cv-00007-GMS, 159 in 1:10-cv-01078-GMS, 30 in 1:11-cv-00782-GMS) SEALED MOTION for Temporary Restraining Order and a Preliminary Injunction. (Bourke, Mary) (Entered: 04/24/2012)
2012-04-24	115	0		REDACTED VERSION of 111 Answering Brief in Opposition by Watson Laboratories Inc.. (Phillips, John) (Entered: 04/24/2012)
2012-05-01	116	0		REDACTED VERSION of (112 in 1:10-cv-00007-GMS) Reply Brief, (171 in 1:10-cv-01078-GMS) Reply Brief, (106 in 1:10-cv-00055-GMS) Reply Brief, (107 in 1:10-cv-00210-GMS) Reply Brief, (42 in 1:11-cv-00782-GMS) Reply Brief, (279 in 1:10-md-02200-GMS) Reply Brief, (117 in 1:09-cv-00954-GMS) Reply Brief, (127 in 1:10-cv-00695-GMS) Reply Brief by Cephalon France, Cephalon Inc., Cephalon, Inc.. (Bourke, Mary) (Entered: 05/01/2012)
2012-05-01	117	0		REDACTED VERSION of (108 in 1:10-cv-00210-GMS, 172 in 1:10-cv-01078-GMS, 280 in 1:10-md-02200-GMS, 107 in 1:10-cv-00055-GMS, 43 in 1:11-cv-00782-GMS, 113 in 1:10-cv-00007-GMS, 118 in 1:09-cv-00954-GMS, 128 in 1:10-cv-00695-GMS) Declaration, by Cephalon France, Cephalon Inc., Cephalon, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5 - 11, # 6 Exhibit 12, # 7 Exhibit 13, # 8 Exhibit 14, # 9 Exhibit 15)(Bourke, Mary) (Entered: 05/01/2012)
2012-05-29	118	0		Joint Letter to The Honorable Gregory M. Sleet from Mary W. Bourke regarding Pretrial Conference. (Bourke, Mary) (Entered: 05/29/2012)
2012-07-11	119	0		Letter to The Honorable Gregory M. Sleet from Mary W. Bourke regarding Asserted Claims. (Bourke, Mary) (Entered: 07/11/2012)
2012-07-13	120	0		STIPULATION Regarding Notice of Intent to Launch by Cephalon France, Cephalon Inc., Watson Laboratories Inc.. (Phillips, John) (Entered: 07/13/2012)
2012-07-16	121	0		Letter to The Honorable Gregory M. Sleet from Mary W. Bourke regarding Request to bring Laptops and devices into Courtroom. (Attachments: # 1 Text of Proposed Order)(Bourke, Mary) (Entered: 07/16/2012)
2012-07-18	122	0		SO ORDERED, re (120 in 1:10-cv-00007-GMS, 296 in 1:10-md-02200-GMS) Stipulation filed by Watson Laboratories Inc., Cephalon France, Cephalon Inc. Signed by Chief Judge Gregory M. Sleet on 7/18/2012. (asw) (Entered: 07/18/2012)
2012-07-23	123	0		MOTION for Judgment as a Matter of Law (Plaintiffs' Rule 52(c)) - filed by Cephalon France, Cephalon Inc., Cephalon, Inc.. (Attachments: # 1 Text of Proposed Order, # 2 Exhibit JTX-0001, # 3 Exhibit JTX-0103)(Bourke, Mary) (Entered: 07/23/2012)
2012-07-31	124	0		ANSWERING BRIEF in Opposition re 123 MOTION for Judgment as a Matter of Law (Plaintiffs' Rule 52(c)) filed by Watson Laboratories Inc..Reply Brief due date per Local Rules is 8/10/2012. (Phillips, John) (Entered: 07/31/2012)
2012-09-13	125	0		Joint STIPULATION Regarding Post-Trial Briefing by Cephalon France, Cephalon Inc., Apotex, Inc., Cephalon, Inc., Apotex Inc.. (Bourke, Mary) (Entered: 09/13/2012)
2012-09-24	126	0		NOTICE of Appearance by Jeffrey B. Bove on behalf of Cephalon France, Cephalon Inc., Cephalon, Inc. (Bove, Jeffrey) (Entered: 09/24/2012)
2012-09-24	127	0		NOTICE of Appearance by Alan Richard Silverstein on behalf of Cephalon France, Cephalon Inc., Cephalon, Inc. (Silverstein, Alan) (Entered: 09/24/2012)
2012-09-25	128	0		SO ORDERED, re (303 in 1:10-md-02200-GMS, 116 in 1:10-cv-00055-GMS, 183 in 1:10-cv-01078-GMS, 125 in 1:10-cv-00007-GMS, 139 in 1:10-cv-00695-GMS, 117 in 1:10-cv-00210-GMS, 53 in 1:11-cv-00782-GMS) Stipulation filed by Cephalon, Inc., Apotex, Inc., Apotex Inc., Cephalon France, Cephalon Inc. Signed by Chief Judge Gregory M. Sleet on 9/25/2012. (asw) (Entered: 09/25/2012)
2012-09-25	129	0		NOTICE of Withdrawal of Attorney Mayssam H. Ali by Cephalon France, Cephalon Inc., Cephalon, Inc. (Bove, Jeffrey) (Entered: 09/25/2012)
2012-09-28	130	0		NOTICE of Withdrawal of Counsel, Mary W. Bourke by Cephalon France, Cephalon Inc., Cephalon, Inc. (Bove, Jeffrey) (Entered: 09/28/2012)
2012-10-17	131	0		POST TRIAL BRIEF Plaintiffs' Proposed Findings of Fact and Conclusions of Law by Cephalon France, Cephalon Inc., Cephalon, Inc.. (Bove, Jeffrey) (Entered: 10/17/2012)
2012-10-17	132	0		POST TRIAL BRIEF Proposed Findings of Fact and Conclusions of Law by Watson Laboratories Inc., Apotex Inc., Lupin Limited, Sandoz Inc.. (Phillips, John) (Entered: 10/17/2012)
2012-10-24	133	0		STIPULATION TO EXTEND TIME to Submit Joint Appendix and Hyper-Linked Post Trial Briefs to November 2, 2012 - filed by Watson Laboratories Inc.. (Haney, Megan) (Entered: 10/24/2012)
2012-11-02	134	0		STIPULATION TO EXTEND TIME to Submit Hyper-Linked Post-Trial Briefs and Joint Appendix to November 7, 2012 - filed by Watson Laboratories Inc.. (Haney, Megan) (Entered: 11/02/2012)
2012-11-07	135	0		NOTICE of filing the following document(s) in multi media format: Letter to The Honorable Gregory M. Sleet re enclosed CD containing hyperlinked Post Trial Brief. Original material(s) to be filed with the Clerk's Office. Notice filed by Jeffrey B. Bove on behalf of All Plaintiffs (Attachments: # 1 Certificate of Service)(Bove, Jeffrey) (Entered: 11/07/2012)
2012-11-07	136	0		Proposed Findings of Fact by Watson Laboratories Inc.. (Phillips, John) (Entered: 11/07/2012)
2012-11-07	137	0		Joint APPENDIX of Documents Cited in Parties' Proposed Findings of Fact and Conclusions of Law by Cephalon France, Cephalon Inc., Cephalon, Inc.. (Attachments: # 1 Certificate of Service)(Bove, Jeffrey) (Entered: 11/07/2012)
2012-12-28	138	0		MOTION to Amend/Correct Motion to Add Teva Sant As A Party-Plaintiff and to Amend the Caption - filed by Cephalon France, Cephalon Inc., Cephalon, Inc.. (Attachments: # 1 Text of Proposed Order, # 2 Certificate of Compliance Local Rule 7.1.1, # 3 Exhibit A, # 4 Exhibit B, # 5 Exhibit C, # 6 Certificate of Service)(Bove, Jeffrey) (Entered: 12/28/2012)
2013-02-01	139	0		Letter to The Honorable Gregory M. Sleet from John C. Phillips, Jr. regarding Subsequent Authority. (Phillips, John) (Entered: 02/01/2013)
2013-02-01	140	0		Supplemental Disclosure Statement pursuant to Rule 7.1 filed by Watson Laboratories Inc. identifying Corporate Parent Actavis, Inc. for Watson Laboratories Inc... (Phillips, John) (Entered: 02/01/2013)
2013-02-06	141	0		NOTICE of Withdrawal of Counsel Alan R. Silverstein by Cephalon France, Cephalon Inc., Cephalon, Inc., Teva Sante SAS (Bove, Jeffrey) (Entered: 02/06/2013)
2013-02-06	142	0		NOTICE of Firm Name Change by Cephalon France, Cephalon Inc., Cephalon, Inc., Teva Sante SAS (Bove, Jeffrey) (Entered: 02/06/2013)
2013-02-08	143	0		Letter to The Honorable Gregory M. Sleet from Jeffrey B. Bove, Esquire regarding Subsequent Authority - re (323 in 1:10-md-02200-GMS) Letter. (Bove, Jeffrey) (Entered: 02/08/2013)
2013-03-30	144	0		MEMORANDUM AND ORDER re (123 in 1:10-cv-00007-GMS, 114 in 1:10-cv-00055-GMS, 51 in 1:11-cv-00782-GMS, 136 in 1:10-cv-00695-GMS, 115 in 1:10-cv-00210-GMS, 180 in 1:10-cv-01078-GMS, 300 in 1:10-md-02200-GMS) MOTION for Judgment as a Matter of Law (Plaintiffs' Rule 52(c)) filed by Cephalon, Inc., Cephalon France, Cephalon Inc., (122 in 1:10-cv-00055-GMS, 59 in 1:11-cv-00782-GMS, 145 in 1:10-cv-00695-GMS, 123 in 1:10-cv-00210-GMS, 189 in 1:10-cv-01078-GMS, 314 in 1:10-md-02200-GMS, 131 in 1:10-cv-00007-GMS) POST Trial Brief filed by Cephalon, Inc., Cephalon France, Cephalon Inc., (319 in 1:10-md-02200-GMS, 128 in 1:10-cv-00210-GMS) Proposed Findings of Fact filed by Armodafinil Patent Litigation, Lupin Pharmaceuticals Inc., Lupin Limited. Signed by Chief Judge Gregory M. Sleet on 3/30/2013. Associated Cases: 1:10-md-02200-GMS et al.(asw) (Entered: 04/01/2013)
2013-03-30	145	0		JUDGMENT in favor of Cephalon France, Cephalon Inc., and Teva Sante SAS; and against Apotex Inc., Lupin Limited, Sandoz Inc., Watson Laboratories Inc. Signed by Chief Judge Gregory M. Sleet on 3/30/2013. Associated Cases: 1:10-md-02200-GMS et al.(asw) (Entered: 04/01/2013)
2013-04-29	146	0		NOTICE OF APPEAL to the Federal Circuit of 144 Memorandum and Order,,, 145 Judgment, . Appeal filed by Watson Laboratories Inc.. (Phillips, John) (Entered: 04/29/2013)
2013-05-13	147	0		TRANSCRIPT REQUEST by Watson Laboratories Inc. Transcript Not Needed (Phillips, John) (Entered: 05/13/2013)
2013-04-30	148	0		NOTICE of Docketing Record on Appeal from USCA for the Federal Circuit re 146 Notice of Appeal (Federal Circuit) filed by Watson Laboratories Inc. USCA Case Number 13-1371 (mmm) (Entered: 05/13/2013)
2013-08-16	149	0		MOTION for Christopher Y. Chan to Withdraw as Attorney - filed by Cephalon France, Cephalon Inc., Cephalon, Inc., Teva Sante SAS. (Bove, Jeffrey) (Entered: 08/16/2013)
2014-06-11	150	0		Joint MOTION to Alter Judgment of March 30, 2013 as to Watson - filed by Watson Laboratories Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2)(Phillips, John) (Entered: 06/11/2014)
2014-06-17	151	0		STIPULATED AMENDED JUDGMENT - re 145 Judgment: in favor of Cephalon France, Cephalon Inc. against Watson Laboratories Inc. Signed by Chief Judge Gregory M. Sleet on 6/13/2014. (mdb) (Entered: 06/17/2014)
2014-06-30	152	0		MANDATE of USCA as to 146 Notice of Appeal (Federal Circuit) filed by Watson Laboratories Inc.. USCA Decision: Appeal is dismissed. (Attachments: # 1 USCA Order)(mdb) (Entered: 06/30/2014)
2014-07-08	153	0		ORDER AND NOTICE REGARDING RETURN OF SEALED DOCUMENTS: Pursuant to the attached STANDING ORDER dated January 8, 2013, sealed documents identified on the highlighted docket sheet will be claimed by the FILING party/attorney no later than 7/22/14. Filing attorney or their designee shall CLAIM their sealed documents by sending an E-MAIL, Subject: Return of Sealed Documents, to returnsealeddocs@ded.uscourts.gov, listing the case number and a contact's name, phone number and address. Parties not registered in CM/ECF may call our Help Desk at 302-573-6170 to claim their sealed documents. Once sealed documents are claimed, THE CLERK SHALL prepare receipts and contact filers WHEN THEIR DOCUMENTS ARE READY FOR PICK-UP at the Clerk's Office, 844 N. King Street, Intake Help Desk, Room 4209. Documents not claimed shall be unsealed and handled pursuant to the standing order. (Attachments: # 1 Highlighted Docket Sheet) (cla, ) (Entered: 07/08/2014)
2014-07-10	154	0		ACKNOWLEDGMENT OF RECEIPT of the following sealed documents, signed on behalf of Novak Druce Connolly Bove + Quigg : D.I. # 94, 112, 113 (cla, ) (Entered: 07/10/2014)
2014-07-10	155	0		ACKNOWLEDGMENT OF RECEIPT of the following sealed documents, signed on behalf of Phillips Goldman & Spence : D.I. # 91, 111 (cla, ) (Additional attachment(s) added on 7/14/2014: # 1 Additional Documents) (cla, ). Modified on 7/14/2014 (cla, ). (Entered: 07/10/2014)